- Anniversary/History
- Membership
- Publications
- Resources
- Education
- Events
- Advocacy
- Careers
- About
- For Pain Patients and Professionals
2021 Jan 21
CNS Neurol Disord Drug Targets
Over the past three decades, NMDA-receptor antagonists have been shown to be efficient drugs for treating pain and particularly pain that is resistant to conventional analgesics. Emphasis will be on the old-new drugs, ketamine and magnesium and their combination as a novel approach for treating chronic pain.